Program for Appropriate Technology in Health

Recent papers from Program for Appropriate Technology in Health

1. Enabling equitable global health AI with privacy‑enhancing technologiesnpj Digital Medicine · 2026
2. Spendworth Frontier Method2026
3. Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in IndiaNature Communications · 2026
4. Art Gallery Advocacy: Raising Awareness About the Full Lives of Children with Medical ComplexityJournal of Palliative Medicine · 2026
5. Staged, life-cycle approach to evidence generation for digital health interventions in low- and middle-income countriesBMJ Digital Health & AI · 2026
6. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet · 2015
7. Distribution of kdr-west and kdr-east resistance alleles in Anopheles gambiae s.l. across contrasting transmission settings in central and southern SenegalMalaria Journal · 2026
8. Harms associated with engaging with AI for mental health support: A scoping review protocolWellcome Open Research · 2026
9. Economic and health burden of severe respiratory syncytial virus infection among hospitalised children at three tertiary hospitals in Argentina, Brazil, and Colombia: a two-year prospective multicentre cohort studyThe Lancet Regional Health - Americas · 2026
10. Patient radiation dose in diagnostic cerebral angiography for intracranial aneurysm: local diagnostic reference levels from a single-center study in ThailandRadiation Protection Dosimetry · 2026
11. Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai AdultsVaccines · 2026
12. A qualitative study exploring factors associated with the accuracy of recording malaria rapid diagnostic test results in two high-burden regions of Côte d’IvoireMalaria Journal · 2026
13. Clinical presentation of severe malaria in children who received the RTS,S/AS01E malaria vaccine, seasonal malaria chemoprevention or the combination of both interventions in Burkina Faso and MaliMalaria Journal · 2026
14. Persistence of Serum Bactericidal Antibody in the First 2-Years After Immunization with Pentavalent Meningococcal ACWYX Vaccine in Malian Infants and ToddlersClinical Infectious Diseases · 2026
15. Human evaluators vs. LLM-as-a-Judge: toward scalable evaluation of GenAI in global healthnpj Digital Medicine · 2026
16. Global sectoral and funding disparities in data-driven climate innovation using BERTopicDiscover Sustainability · 2026
17. Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite proteinnpj Vaccines · 2026
18. Prevalence of molecular markers related to artemisinin partial resistance and ACT partner drug resistance in the Plasmodium falciparum population in Kongo Central, DRCMalaria Journal · 2026
19. Benchmarking large language models and clinicians using locally generated primary healthcare vignettes in KenyaBMJ Digital Health & AI · 2026
20. Generative AI-enabled clinical decision support system in primary care: a pragmatic, cluster-randomized trialNature Medicine · 2026